---
title: "JXPCB: Net profit loss of 13.5059 million yuan in the third quarter"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/262588165.md"
description: "JXPCB announced that its revenue for the third quarter was 196 million yuan, a year-on-year increase of 65.28%; the net profit loss was 13.5059 million yuan. Revenue for the first three quarters was 488 million yuan, a year-on-year increase of 40.48%; the net profit loss was 16.272 million yuan"
datetime: "2025-10-24T09:50:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/262588165.md)
  - [en](https://longbridge.com/en/news/262588165.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/262588165.md)
---

# JXPCB: Net profit loss of 13.5059 million yuan in the third quarter

JXPCB announced that its revenue for the third quarter was 196 million yuan, a year-on-year increase of 65.28%; the net profit loss was 13.5059 million yuan. Revenue for the first three quarters was 488 million yuan, a year-on-year increase of 40.48%; the net profit loss was 16.272 million yuan

### Related Stocks

- [688655.CN](https://longbridge.com/en/quote/688655.CN.md)

## Related News & Research

- [BYD IN TALKS WITH CHRISTIAN HORNER OVER ENTERING F1 – FT](https://longbridge.com/en/news/287236664.md)
- [Orkla (OB:ORK) Margin Improvement Challenges Cautious Earnings Narratives Heading Into Q1 2026](https://longbridge.com/en/news/287134604.md)
- [IMF: IMF STAFF CONCLUDE A MISSION TO CHAD](https://longbridge.com/en/news/287253313.md)
- [Aker BP insider sells shares worth NOK 1.17 million](https://longbridge.com/en/news/287249459.md)
- [Mabwell Wins Wider China Indications for Denosumab Biosimilar as Global Push Accelerates](https://longbridge.com/en/news/287103520.md)